Interferon beta-1a candidate for COPD advances to PhIII to test its potential against Covid-19
Another repurposed drug is entering Phase III to see if it passes the test against Covid-19.
In a small Phase II trial, Synairgen says hospitalized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
